ArticleUrolithiasis2024
A new scoring system to predict febrile urinary tract infection after retrograde intrarenal surgery.
Article in Urolithiasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Urinary Tract Infectious Complications After Retrograde Intrarenal Surgery: The RIRS-STAMP Risk Score from a Two-Center Cohort.Pathogens (Basel, Switzerland) · 2026Article
- Risk factors for postoperative febrile urinary tract infection in patients with urolithiasis: a meta-analysis.Frontiers in surgery · 2026Article
- Risk factors for urosepsis in diabetic patients with renal and ureteral calculi: A retrospective study.World journal of diabetes · 2025Article
- Article
- Use of Artificial Intelligence Methods for Improved Diagnosis of Urinary Tract Infections and Urinary Stone Disease.Journal of clinical medicine · 2025Review
- Exploring the application of FANS-UAS in pediatric kidney stone treatment.World journal of urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study aimed to determine the risk factors and define a new scoring system for predicting febrile urinary tract infection (F-UTI) following retrograde intrarenal surgery (RIRS) by using machine learning methods. We retrospectively analyzed the medical records of patients who underwent RIRS and 511 patients were included in the study. The patients were divided into two groups: Group 1 consisted of 34 patients who developed postoperative F-UTI, and Group 2 consisted of 477 patients who did not. We applied feature selection to determine the relevant variables. Consistency subset evaluator and greedy stepwise techniques were used for attribute selection. Logistic regression analysis was conducted on the variables obtained through feature selection to develop our scoring system. The accuracy of discrimination was assessed using the receiver operating characteristic curve. Five of the 19 variables, namely diabetes mellitus, hydronephrosis, administration type, a history of post-ureterorenoscopy (URS) UTI, and urine leukocyte count, were identified through feature selection. Binary logistic regression analysis showed that hydronephrosis, a history of post-URS UTI, and urine leukocyte count were significant independent predictors of F-UTI following RIRS. These three factors demonstrated good discrimination ability, with an area under curve value of 0.837. In the presence of at least one of these factors, 32 of 34 patients (94.1%) who developed postoperative F-UTI were successfully predicted. This new scoring system developed based on hydronephrosis, a history of post-URS UTI, and urine leukocyte count can successfully discriminate patients at risk of F-UTI development after RIRS.
Indexed as
Identifiers
39718583What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.